ELDN
ELDN
NASDAQ · Biotechnology

Eledon Pharmaceuticals Inc

$2.83
-0.13 (-4.39%)
As of Mar 29, 10:37 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +327.2% upside
Low Target $9.42
Average Target $12.09
High Target $15.53
Current Price $2.83
Current
$2.83
Target
$12.09
$9.42 $12.09 avg $15.53
Scenario Analysis
Bear Case
$9.42
232.9%
Low target
Base Case
$12.09
+327.2%
Avg target
Bull Case
$15.53
+448.8%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.60
-38.5% from high
52-Week Low
$1.35
+109.6% from low
Target vs 52W High
$12.09
+162.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%